Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine – Review

被引：0
|
作者：
Bárbara Torrecillas-Baena
María Ángeles Gálvez-Moreno
José Manuel Quesada-Gómez
Gabriel Dorado
Antonio Casado-Díaz
机构：
[1] Hospital Universitario Reina Sofía,Unidad de Gestión Clínica de Endocrinología y Nutrición
[2] CIBERFES, GC17, Instituto Maimónides de Investigación Biomédica de Córdoba
[3] Universidad de Córdoba,Dep. Bioquímica y Biología Molecular, Campus Rabanales C6
[4] CIBERFES,1
来源：
Stem Cell Reviews and Reports | 2022年 / 18卷
关键词：
Dipeptidyl peptidase 4; Mesenchymal stem-cells; Dipeptidyl peptidase-4 inhibitor; Dipeptidyl peptidase-4 substrate; Wound healing; Regenerative medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：56 / 76
页数：20
相关论文
共 50 条
  • [31] Dipeptidyl peptidase 4 ( DPP4) inhibitor enhances natural killer cell chemotaxis, improving tumor immunity against hepatocellular carcinoma
    Nishina, Sohji
    Yamauchi, Akira
    Hara, Yuichi
    Sasaki, Kyo
    Hino, Keisuke
    HEPATOLOGY, 2016, 64 : 237A - 237A
  • [32] Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors
    Anderluh, Marko
    Kocic, Gordana
    Tomovic, Katarina
    Kocic, Radivoj
    Deljanin-Ilic, Marina
    Smelcerovic, Andrija
    PHARMACOLOGY & THERAPEUTICS, 2016, 167 : 100 - 107
  • [33] Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis
    Overbeek, Jetty A.
    Bakker, Marina
    van der Heijden, Amber A. W. A.
    van Herk-Sukel, Myrthe P. P.
    Herings, Ron M. C.
    Nijpels, Giel
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (05)
  • [34] The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves insulin sensitivity and β-cell function in subjects with impaired fasting glucose
    Jacobsen, Lisbeth V.
    Hindsberger, Charlotte
    Robson, Richard
    Zdravkovic, Milan
    DIABETES, 2007, 56 : A137 - A137
  • [35] Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats
    Al-Ghamdi, Maryam A.
    Moselhy, Said S.
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2023, 30 (12) : 33942 - 33948
  • [36] SERUM DIPEPTIDYL PEPTIDASE-4 LEVELS AND DPP4 RS17574 POLYMORPHISM IN SUBCLINICAL ATHEROSCLEROSIS INDIVIDUALS WITH AND WITHOUT FATTY LIVER. THE GEA MEXICAN STUDY
    Posadas-Sanchez, R.
    Hernandez-Diaz Couder, A.
    Sanchez-Munoz, F. S. -M.
    Vargas-Alarcon, G.
    ATHEROSCLEROSIS, 2022, 355 : E133 - E134
  • [37] Inhibition of dipeptidyl peptidase-4 (DPP4), antioxidant, antiglycation and anti-inflammatory effect of Ferulic acid against streptozotocin toxicity mediate nephropathy in diabetic rats
    Maryam A. AL-Ghamdi
    Said S. Moselhy
    Environmental Science and Pollution Research, 2023, 30 : 33942 - 33948
  • [38] DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment
    Wilson, Jessica R.
    Garner, Erica M.
    Mashayekhi, Mona
    Hubers, Scott A.
    Bustamante, Claudia E. Ramirez
    Kerman, Scott Jafarian
    Nian, Hui
    Shibao, Cyndya A.
    Brown, Nancy J.
    HYPERTENSION, 2022, 79 (04) : 827 - 835
  • [39] Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: Possible implications for the hypothalamic neuropeptidergic system
    Stephan, Michael
    Radicke, Anna
    Leutloff, Sandra
    Schmiedl, Andreas
    Pabst, Reinhard
    von Hoersten, Stephan
    Dettmer, Sabine
    Lotz, Joachim
    Nave, Heike
    BEHAVIOURAL BRAIN RESEARCH, 2011, 216 (02) : 712 - 718
  • [40] Risk of diabetic ketoacidosis with sodium-glucose transporter-2 inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors and sulfonylureas in patients with type 2 diabetes
    Dawwas, Dawwas
    Leonard, Charles E.
    Lewis, James D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 54 - 55
12345